Gary Nieman Selected Research

Gary Nieman Research Topics

Disease

11	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022 - 04/2003
9	Lung Injury 01/2022 - 04/2003
9	Sepsis (Septicemia) 01/2015 - 02/2005
7	Inflammation (Inflammations) 01/2022 - 01/2012
7	Ventilator-Induced Lung Injury 12/2018 - 03/2005
5	Edema (Dropsy) 01/2022 - 08/2012
5	Acute Lung Injury 01/2022 - 03/2005
5	Pneumonia (Pneumonitis) 01/2022 - 09/2005
3	Wounds and Injuries (Trauma) 01/2022 - 01/2012
2	Hemorrhage 01/2022 - 01/2012
2	Respiratory Insufficiency (Respiratory Failure) 01/2021 - 01/2015
2	Ischemia 01/2015 - 01/2013
2	Pulmonary Edema 08/2012 - 02/2005
2	Septic Shock (Toxic Shock Syndrome) 01/2007 - 10/2005
2	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 09/2005 - 12/2002
1	Pulmonary Arterial Hypertension 01/2022
1	Emphysema 01/2022
1	COVID-19 01/2021
1	Bacterial Pneumonia 04/2016
1	Critical Illness (Critically Ill) 04/2015
1	Acute Kidney Injury (Acute Renal Failure) 01/2015
1	Acidosis 01/2015
1	Multiple Organ Failure (MODS) 11/2012
1	Thrombosis (Thrombus) 10/2005
1	Reperfusion Injury 10/2005
1	Body Weight (Weight, Body) 03/2005
1	Clinical Deterioration 02/2005
1	Bacteremia 02/2005

Drug/Important Bio-Agent (IBA)

4	Surface-Active Agents (Surfactants)IBA 11/2013 - 04/2003
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 04/2015
3	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 10/2005
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2005
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 04/2015
3	CytokinesIBA 01/2021 - 02/2005
3	Biological ProductsIBA 01/2018 - 01/2012
3	tetracycline CMT-3IBA 01/2015 - 10/2005
3	Tetracycline (Achromycin)FDA LinkGeneric 01/2015 - 10/2005
2	AmphiregulinIBA 01/2022 - 01/2018
2	LipopolysaccharidesIBA 01/2022 - 01/2018
2	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2022 - 10/2005
1	Interleukin-18 (Interleukin 18)IBA 01/2022
1	Pancreatic Elastase (Elastase)IBA 01/2022
1	Caspase 1 (ICE Protease)IBA 01/2022
1	Smart MaterialsIBA 01/2022
1	InflammasomesIBA 01/2022
1	progelatinaseIBA 01/2022
1	Biocompatible Materials (Biomaterials)IBA 01/2022
1	Metalloproteases (Metalloproteinases)IBA 01/2022
1	Hemostatics (Antihemorrhagics)IBA 01/2022
1	Oxygen (Dioxygen)IBA 01/2021
1	CollagenIBA 01/2018
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2018
1	SyndecansIBA 01/2018
1	DecorinIBA 01/2018
1	CurcuminIBA 04/2016
1	1,7- bis(4- hydroxyphenyl)- 4- N- phenylaminocarbonylhepta- 1,6- dien- 3,5- dioneIBA 04/2016
1	Polysorbates (PSML)FDA Link 11/2014
1	Pulmonary Surfactant-Associated Protein A (Surfactant Protein A)IBA 01/2013
1	salicylhydroxamic acid (SHAM)IBA 01/2013
1	Cadherins (E-Cadherin)IBA 01/2013
1	GasesIBA 01/2013
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2012
1	AlarminsIBA 01/2012
1	Pharmaceutical PreparationsIBA 12/2011
1	drotrecogin alfa activated (Xigris)FDA Link 12/2011
1	Peptide Hydrolases (Proteases)FDA Link 10/2005
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 02/2005

Therapy/Procedure

12	Artificial Respiration (Mechanical Ventilation) 12/2018 - 04/2003
8	Continuous Positive Airway Pressure 01/2021 - 01/2013
5	Therapeutics 01/2013 - 12/2011
3	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 01/2021 - 01/2007
3	Mechanical Ventilators (Ventilator) 11/2014 - 02/2006
2	Critical Care (Surgical Intensive Care) 01/2021 - 02/2005
2	Cardiopulmonary Bypass (Heart-Lung Bypass) 09/2005 - 12/2002
1	Length of Stay 04/2015
1	Anesthesia 08/2012
1	Laparotomy 10/2005
1	Oxygenators 03/2005